Tradestie Institutional Equity Comparison Engine

SCYX vs AQST โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AQST Overall Edge

AQST Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aquestive Therapeutics, Inc. Common Stock (AQST) driven by superior Growth & Margin, Options & Structure while SCYX counters with relative strength in Valuation, Momentum & Technical. Fundamentally, SCYX trades at 1.9x Forward P/E with -126.9% operating margin (-82.8% YoY revenue) versus AQST at N/M Forward P/E and -114.1% operating margin (-41.0% YoY). In options structure, SCYX sits in BREAKDOWN (4th %ile IV; Dealer Gamma Walls on Pro) against AQST sits in BREAKDOWN (64th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SCYX
SCYX 1.9x vs AQST N/M Fwd P/E
Growth & Margin Winner AQST
Op Margin -126.9% vs -114.1% ยท YoY -82.8% vs -41.0%
Momentum & Technical Winner SCYX
1Y +303.4% vs -40.6% ยท 52W Pos 33% vs 14%
Options & Structure Winner AQST
BREAKDOWN (4th %ile IV) vs BREAKDOWN (64th %ile IV)
SCYX NASDAQ
SCYNEXIS, Inc.
Pharmaceutical Preparations
$2.38
-8.64% 1D
Market Cap $25.9M
1M Return -37.53%
1Y Return +303.39%
Forward P/E 1.9x
Unified AI Score
42.2 / 100 HOLD
Tech 25.0 Fund 48.0 Flow 65.0 Mom 59.0
AQST NASDAQ
Aquestive Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$3.46
-6.61% 1D
Market Cap $465.7M
1M Return -16.22%
1Y Return -40.65%
Forward P/E N/M
Unified AI Score
62.9 / 100 BUY
Tech 54.0 Fund 68.0 Flow 68.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SCYX +303.39% AQST -40.65% Spread: +344.04 pp (SCYX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SCYX Revenue AQST Revenue SCYX Op. Margin AQST Op. Margin Margin Edge
FY2018 $0M $70M -11666.5% -72.6% AQST
FY2019 $0M $50M -40430.6% -100.1% AQST
FY2020 N/A $50M N/A -93.6% AQST
FY2021 $10M $50M -462.2% -68.2% AQST
FY2022 $10M $50M -1684.5% -88.2% AQST
FY2023 $140M $50M 51.9% -29.9% SCYX
FY2024 $0M $60M -990.8% -53.5% AQST
FY2025 $20M $40M -78.0% -159.5% SCYX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SCYX (4) vs AQST (6)
Institutional Metric SCYX AQST Criterion Row Winner
Market Capitalization Scale $25.9M $465.7M Larger Scale AQST
Trailing P/E Ratio Valuation 1.9x N/M Lower Multiple SCYX
Forward P/E Ratio Valuation 1.9x N/M Lower Multiple SCYX
Revenue Growth (YoY) Growth -82.8% -41.0% Higher Growth AQST
Operating Margin (TTM) Profitability -126.9% -114.1% Higher Margin AQST
Net Profit Margin Profitability -53.5% -162.3% Higher Margin SCYX
Return on Equity (ROE) Capital Efficiency -21.2% 0.0% Higher ROE AQST
52-Week Range Position Momentum 33% ($1โ€“$6) 14% ($3โ€“$7) Stronger Trend SCYX
Beta / 30D Volatility Risk Regime 3.09ฮฒ ยท 73% Vol 0.89ฮฒ ยท 56% Vol Lower Realized Risk AQST
Unified Institutional Score Composite Signal 42.2 / 100 (HOLD) 62.9 / 100 (BUY) Higher Composite AQST

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SCYX vs AQST Buy Guide
SCYX BREAKDOWN
77d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live SCYX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AQST BREAKDOWN
61d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 64th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live AQST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SCYX nor AQST registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.